Hyundai Pharm (004310) - Cash Flow Conversion Efficiency

Latest as of May 2026: 0.019x

Based on the latest financial reports, Hyundai Pharm (004310) has a cash flow conversion efficiency ratio of 0.019x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.39 Billion ≈ $1.62 Million USD) by net assets (₩128.05 Billion ≈ $86.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Hyundai Pharm for the company's overall valuation and market capitalisation.

Hyundai Pharm - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Hyundai Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hyundai Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hyundai Pharm ranked by their cash flow conversion efficiency. Explore Hyundai Pharm earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Ucore Rare Metals Inc V:UCU	-0.080x
Commerce.com, Inc. NASDAQ:CMRC	0.099x
DeFi Technologies Inc. NEO:DEFI	-0.367x
Samsung Sdi Co Pref KO:006405	0.023x
Boa Safra Sementes S.A SA:SOJA3	0.225x
Chung Hwa Food Industrial Co Ltd TWO:4205	0.074x
Honda India Power Products Limited NSE:HONDAPOWER	-0.040x
BAJEL PROJECTS LTD NSE:BAJEL	0.009x

Annual Cash Flow Conversion Efficiency for Hyundai Pharm (2010–2025)

The table below shows the annual cash flow conversion efficiency of Hyundai Pharm from 2010 to 2025. View Hyundai Pharm (004310) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-11-30	₩82.10 Billion ≈ $55.64 Million	₩-123.29 Million ≈ $-83.55K	-0.002x	+95.00%
2024-11-30	₩79.07 Billion ≈ $53.59 Million	₩-2.37 Billion ≈ $-1.61 Million	-0.030x	+44.10%
2023-11-30	₩84.66 Billion ≈ $57.37 Million	₩-4.55 Billion ≈ $-3.08 Million	-0.054x	-139.98%
2022-11-30	₩86.56 Billion ≈ $58.66 Million	₩11.62 Billion ≈ $7.88 Million	0.134x	+126.60%
2021-11-30	₩86.60 Billion ≈ $58.69 Million	₩5.13 Billion ≈ $3.48 Million	0.059x	-50.56%
2020-11-30	₩90.14 Billion ≈ $61.09 Million	₩10.80 Billion ≈ $7.32 Million	0.120x	+50.79%
2019-11-30	₩87.58 Billion ≈ $59.35 Million	₩6.96 Billion ≈ $4.72 Million	0.079x	+200.09%
2018-11-30	₩107.00 Billion ≈ $72.52 Million	₩2.83 Billion ≈ $1.92 Million	0.026x	+231.16%
2017-11-30	₩98.10 Billion ≈ $66.48 Million	₩-1.98 Billion ≈ $-1.34 Million	-0.020x	+26.42%
2016-11-30	₩100.08 Billion ≈ $67.82 Million	₩-2.75 Billion ≈ $-1.86 Million	-0.027x	-134.94%
2013-11-30	₩101.21 Billion ≈ $68.59 Million	₩7.95 Billion ≈ $5.39 Million	0.079x	+390.34%
2012-11-30	₩99.69 Billion ≈ $67.56 Million	₩-2.70 Billion ≈ $-1.83 Million	-0.027x	-145.03%
2011-11-30	₩104.32 Billion ≈ $70.69 Million	₩6.27 Billion ≈ $4.25 Million	0.060x	+107.53%
2010-11-30	₩92.50 Billion ≈ $62.69 Million	₩2.68 Billion ≈ $1.82 Million	0.029x	--

About Hyundai Pharm

KO:004310 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$212.03 Million

₩312.87 Billion KRW

Market Cap Rank

#16409 Global

#602 in Korea

Share Price

₩10120.00

Change (1 day)

+1.30%

52-Week Range

₩3545.00 - ₩14340.00

All Time High

₩14340.00